A Randomized, Double-blind, Multi-center, Three Arm (Pritelivir, Placebo and Zovirax®) Parallel Group, Comparative Trial to Assess the Efficacy and Safety of Pritelivir 5% w/w Ointment for the Treatment of Recurrent Herpes Labialis in Adults - LipP1
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Pritelivir (Primary) ; Aciclovir
- Indications Herpes labialis
- Focus Therapeutic Use
- Sponsors AiCuris
- 10 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Aug 2017.
- 10 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2017.
- 26 Jun 2017 Status changed from recruiting to active, no longer recruiting.